Air Pollution Can Trigger Diabetes

Air Pollution Can Trigger Diabetes

Lifestyles and excess calories in the body have been the cause of
The main type 2 diabetes. But it turns out there are additional factors that helped trigger the development of disease
diabetes, namely air pollution.

Why air pollution trigger diabetes?

Here’s an explanation from the scientists at Children’s Hospital, Boston, to be published in the October issue of Diabetes Care. If the particles of air pollution is too much that enters the body, the body will become inflamed.

Well, this inflammation will interfere with the action of insulin. Due to impaired insulin resistance will happen (rejection) of insulin in the body that makes people get diabetes.

This finding is consistent with previous laboratory research that found that insulin resistance is increased in rats exposed to particle pollution in the air and also an increase in markers of inflammation that can contribute to insulin resistance.

In the latest study, researchers focused on fine particles measuring 0.1 to 2.5 nanometers, or known as PM2.5, which is the main component found in fog and smoke exhaust from motor vehicles. The result, for each 10 g/m3 increase in PM2.5 exposure, there is increased 1 percent prevalence of diabetes.

“In addition to research in the laboratory, we also incorporate data from the Environmental Protection Agency (EPA) with data from the Centers for Disease Control (CDC) and U.S. census to ensure the prevalence of diabetes of adults,” said John Brownstein, PhD, of Children’s Hospital Informatics Program, such as quoted from Medindia on Thursday (09/30/2010).

According to Brownstein, with risk factors for diabetes are well known, such as obesity, geographic latitude, ethnicity and population density (a measure of urbanization), then air pollution may be one trigger development of diabetes.

“Many environmental factors that can contribute to the epidemic of diabetes around the world. In addition to excess calories, pollution could become an additional factor,” notes Allison Goldfine, MD, head of clinical research at Joslin Diabetes Center.